Rivka Inzelberg

The Sagol Neuroscience Center, Department of Neurology, Sheba Medical Center, Israel

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Neurological Disorders > Movement Disorders (since 14 November 2005)

All recent recommendations

• 3.0
  Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
  Recommended by Rivka Inzelberg
  
• 3.2
  Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).
  Recommended by Rivka Inzelberg, Stewart Factor
  
• 6.0
  Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?
  Recommended by Rivka Inzelberg
  
• 3.0
  Pesticide exposure and risk for Parkinson's disease.
  Recommended by Rivka Inzelberg
  
• 4.9
  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.
  Recommended by Massimo Pandolfo, Simon Lovestone, Rivka Inzelberg
  
• 3.0
  Loss of autophagy in the central nervous system causes neurodegeneration in mice.
  Recommended by Rivka Inzelberg
  
• 3.0
  Leisure activity and risk of cognitive impairment: the Chongqing aging study.
  Recommended by Rivka Inzelberg
  
• 3.2
  A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
  Recommended by Irene Litvan, Rivka Inzelberg
  
• 6.4
  Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.
  Recommended by X.William Yang, Rivka Inzelberg